Literature DB >> 12434689

Guidelines for public health management of meningococcal disease in the UK.

.   

Abstract

Following changes in the epidemiology of meningococcal disease, the advent of new vaccines, and with new evidence on risk and control measures, the Public Health Laboratory Service Meningococcus Forum set up a Working Group to review the guidance for control measures in the UK. This review is based on available evidence, and recommendations are graded according to the level of evidence on which they are based. These guidelines cover pre-admission management, investigation of suspected cases, the role of public health, public health action after a single case, prophylaxis in healthcare settings, and management of clusters. Detailed revised recommendations are presented on the use of antibiotics before admission to hospital, the rationale and indications for chemoprophylaxis, and the use of new vaccines. Links to relevant websites are included.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434689

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  11 in total

1.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Genotypic characterization of Neisseria meningitidis using Pyrosequencing.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

3.  Prehospital parenteral penicillin for meningitis: Trial in children with suspected meningococcal disease would be useful.

Authors:  D Graham Mackenzie; Charles J P Saunders; Diptendu N Bhattacharyya; Chris R Steer
Journal:  BMJ       Date:  2006-06-17

Review 4.  Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials.

Authors:  A Fraser; A Gafter-Gvili; M Paul; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

5.  Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.

Authors:  J Granerod; K L Davison; M E Ramsay; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2006-02-22       Impact factor: 2.451

Review 6.  Antibiotics for preventing meningococcal infections.

Authors:  Anca Zalmanovici Trestioreanu; Abigail Fraser; Anat Gafter-Gvili; Mical Paul; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2013-10-25

7.  Detection of Neisseria meningitidis DNA from skin lesion biopsy using real-time PCR: usefulness in the aetiological diagnosis of purpura fulminans.

Authors:  Pierre Staquet; Ludovic Lemee; Eva Verdier; Guy Bonmarchand; Vincent Laudenbach; Christine Michel; Jean-Francois Lemeland; Stephane Marret; Thierry Blanc
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

8.  Meningococcal disease serogroup C.

Authors:  Félix O Dickinson; Antonio E Pérez; Iván E Cuevas
Journal:  Risk Manag Healthc Policy       Date:  2012-03-08

9.  Saliva and meningococcal transmission.

Authors:  Hilary J Orr; Steve J Gray; Mary Macdonald; James M Stuart
Journal:  Emerg Infect Dis       Date:  2003-10       Impact factor: 6.883

10.  Geographic correlation between deprivation and risk of meningococcal disease: an ecological study.

Authors:  Christopher J Williams; Lorna J Willocks; Iain R Lake; Paul R Hunter
Journal:  BMC Public Health       Date:  2004-07-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.